For the calculation of corneal power, using a single value for a keratometric index (nk) is imprecise and may lead to significant clinical errors, warn researchers of a recent study.
For the calculation of corneal power, using a single value for a keratometric index (nk) is imprecise and may lead to significant clinical errors, warned researchers of a recent study published in the journal Cornea.
These researchers sought to theoretically analyse the errors in the central corneal power calculation in eyes with keratoconus when an nk is used and to clinically confirm the errors induced using this approach.
They simulated and evaluated theoretically the differences ΔPc between central corneal power estimation with the classical nk (Pk) and the Gaussian equations in eyes with keratoconus. They considered the potential range of variation of the central radius of curvature of the anterior (r1c) and posterior (r2c) corneal surfaces, and studied these differences in a clinical sample that included 44 keratoconic eyes (27 patients aged 14 to 73 years). Clinical agreement between Pk and true net power obtained with a Scheimpflug photography-based topographer was evaluated.
For nk = 1.3375, an overestimation was seen in most cases in the theoretical simulations, with differences ranging from an underestimation of –0.1 D (r1c = 7.9 mm and r2c = 8.2 mm) to an overestimation of 4.3 D (r1c = 4.7 mm and r2c = 3.1 mm). Clinically, Pk always overestimated the Gaussian equation given by the topography system in a range between 0.5 and 2.5 D (P P c was 1.48 D, with limits of agreement of 0.71 and 2.25 D. A very strong statistically significant correlation was bound between ΔPc and r2c (r = –0.93; P
To access the abstract of this study, click here.
AAO 2024: Transient vision loss with Alexander Fein, MD
October 21st 2024Alexander Fein, MD, spoke with the Eye Care Network to share how to approach a patient presenting with transient vision loss, what this type of vision loss can mean, and what additional testing might be needed to determine the best plan for care.
AAO 2024: Optimal pupil size reduction percentage for near vision improvement in presbyopia
October 21st 2024Jennifer Loh, MD, shared insights from on her presentation at the American Academy of Ophthalmology meeting in Chicago on the effects of CSF-1, which is the lowest effective concentration of pilocarpine approved in the United States.